Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.61 CAD | -0.62% | +4.55% | -10.06% |
04-11 | Oncolytics Biotech Inc. Announces the Submission of a Type C Meeting Request to the FDA | CI |
04-11 | Oncolytics Biotech Down 1.8% In US Premarket As Submits Type C Meeting Request to FDA | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.06% | 89.19M | |
+23.12% | 46.4B | |
-1.62% | 41.75B | |
+48.83% | 41.37B | |
-3.42% | 29.71B | |
+9.86% | 26.01B | |
-19.11% | 19.52B | |
+30.32% | 12.43B | |
-0.36% | 12.18B | |
-0.66% | 12.13B |
- Stock Market
- Equities
- ONC Stock
- News Oncolytics Biotech Inc.
- Oncolytics Says Anal Cancer Cohort Of GOBLET Phase 1/2 Study Meets "Criteria For Efficacy"; Provides Update on Pancreatic Cancer Program